NRC Health Common Stock (NRC) Stock Price

NRCStock

$20.15+72.52%52W

Market Cap$446.11M

P/E38.42x

PEG Ratio1.32

Div yield1.16%

Beta0.26

NRC Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)8.35%

Price vs S&P 500 (4W)-3.94%

PEG Ratio1.32

VGM Score39.07

P/E Ratio (Annual)38.42x

Indicated Dividend Yield (Annual)1.16%

P/CF (Annual)16.85x

Book Value / Share (Quarterly)$0.30

P/TBV (Annual)36.15x

Indicated Dividend (Annual)$0.64

Revenue Growth (3Y)-3.23%

Cash Flow / Share (Quarterly)$0.98

Payout Ratio (TTM)99.53%

Price vs S&P 500 (YTD)-4.57%

Gross Margin (TTM)61.75%

Net Profit Margin (TTM)4.19%

EPS (TTM)$0.27

10-Day Avg Trading Volume0.08M

EPS Excl Extra (TTM)$0.27

Revenue Growth (5Y)0.61%

EPS (Annual)$0.52

Dividend / Share (Annual)$0.48

ROI (Annual)12.47%

Gross Margin (Annual)61.88%

Net Profit Margin (5Y Avg)18.58%

Cash / Share (Quarterly)$0.15

P/E Basic Excl Extra (TTM)76.07x

Revenue Growth QoQ (YoY)3.98%

EPS Growth (5Y)-18.62%

P/E Normalized (Annual)38.42x

ROA (Last FY)8.60%

Revenue Growth TTM (YoY)-0.23%

EBITD / Share (TTM)$1.04

ROE (5Y Avg)62.71%

Operating Margin (TTM)10.53%

Cash Flow / Share (Annual)$0.70

P/B Ratio68.06x

P/B Ratio (Quarterly)74.23x

Net Income / Employee (Annual)$32,500

EV / Revenue (TTM)3.80x

Net Interest Coverage (TTM)4.84x

ROA (TTM)4.33%

EPS Growth QoQ (YoY)-41.64%

EV / EBITDA (TTM)23.28x

EPS Incl Extra (Annual)$0.52

Current Ratio (Annual)0.55x

Quick Ratio (Quarterly)0.50x

3-Month Avg Trading Volume0.12M

52-Week Price Return72.52%

EV / Free Cash Flow (Annual)33.82x

P/E Incl Extra (TTM)76.07x

Revenue / Employee (TTM)$392,100

Tangible BV / Share (Quarterly)$0.20

P/S Ratio (Annual)3.24x

Asset Turnover (Annual)1.02x

52-Week High$23.68

Operating Margin (5Y Avg)26.53%

EPS Excl Extra (Annual)$0.52

CapEx CAGR (5Y)21.88%

Tangible BV CAGR (5Y)-28.49%

26-Week Price Return18.25%

Quick Ratio (Annual)0.45x

13-Week Price Return-7.48%

Total Debt / Equity (Annual)5.65x

Current Ratio (Quarterly)0.65x

Enterprise Value$532.41M

Revenue / Share Growth (5Y)3.41%

Asset Turnover (TTM)1.03x

Book Value / Share Growth (5Y)-24.57%

Revenue / Employee (Annual)$384,800

Pretax Margin (Annual)12.99%

Cash / Share (Annual)$0.18

3-Month Return Std Dev55.30%

Gross Margin (5Y Avg)62.26%

Net Income / Employee (TTM)$16,400

EBITDA CAGR (5Y)-9.66%

EBITDA Interim CAGR (5Y)-11.74%

ROE (Last FY)82.92%

Net Interest Coverage (Annual)2.78x

EPS Basic Excl Extra (Annual)$0.52

P/FCF (TTM)20.60x

Receivables Turnover (TTM)12.80x

EV / Free Cash Flow (TTM)24.60x

Total Debt / Equity (Quarterly)13.75x

EPS Incl Extra (TTM)$0.27

Receivables Turnover (Annual)12.22x

ROI (TTM)6.24%

Dividend Growth Rate (5Y)2.80%

P/S Ratio (TTM)3.18x

Pretax Margin (5Y Avg)24.76%

Revenue / Share (Annual)$6.13

Tangible BV / Share (Annual)$0.52

Forward P/E22.66x

Free OCF CAGR (5Y)-15.55%

Price vs S&P 500 (52W)56.99%

P/E Ratio (TTM)76.07x

EPS Growth TTM (YoY)-65.37%

Year-to-Date Return7.35%

5-Day Price Return-1.27%

EPS Normalized (Annual)$0.52

ROA (5Y Avg)20.16%

Net Profit Margin (Annual)8.44%

Month-to-Date Return-4.91%

Cash Flow / Share (TTM)$1.40

EBITD / Share (Annual)$1.35

EPS Growth (3Y)-25.78%

Operating Margin (Annual)16.44%

LT Debt / Equity (Annual)5.36x

P/CF (TTM)15.10x

ROI (5Y Avg)28.38%

P/E Excl Extra (TTM)76.07x

LT Debt / Equity (Quarterly)13.13x

EPS Basic Excl Extra (TTM)$0.27

P/TBV (Quarterly)109.34x

Payout Ratio (Annual)94.64%

P/B Ratio (Annual)30.40x

Dividend / Share (TTM)$0.56

Pretax Margin (TTM)6.70%

Book Value / Share (Annual)$0.62

Price vs S&P 500 (13W)-10.17%

Net Margin Growth (5Y)-21.31%

Dividend Yield (TTM)2.85%

Beta0.26x

P/FCF (Annual)28.31x

Revenue / Share (TTM)$6.36

ROE (TTM)48.47%

52-Week Low$11.20

vGradeD

gGradeD

mGradeB

vgmGradeD

NRC Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Jul 28, 2026	$0.14	$0.31	+121.43%(+$0.17)
Q1 2026	Apr 28, 2026	—	$0.14	—

NRC Analyst Recommendations

Dec 2021

Jul 2026

Aug 2026

Sep 2026

2.25

4.00

Industry Peers — R&D — Physical Sciences(17)

Symbol	Value Score	Growth Score	Momentum Score	P/E Ratio (Annual)	ROE (TTM)	Revenue Growth (5Y)	Indicated Dividend Yield (Annual)	Price
NRCNRC Health Common Stock	D	D	B	38.4x	48.5%	0.6%	1.2%	$20.15
IQVIQVIA Holdings Inc.	D	C	A	32.3x	21.9%	7.5%	—	$266.90
INCYIncyte Genomics Inc	C	B	B	17.8x	29.6%	14.0%	—	$113.07
MEDPMedpace Holdings, Inc. Common Stock	F	B	B	38.3x	110.2%	22.3%	—	$618.47
CRLCharles River Laboratories International, Inc.	F	D	A	—	-7.7%	6.5%	—	$300.15
ICLRIcon Plc	C	C	B	57.3x	0.8%	24.1%	—	$170.18
ABSIAbsci Corporation Common Stock	F	F	B	—	-59.2%	-10.1%	—	$8.25
OABIOmniAb, Inc. Common Stock	F	B	A	—	-16.6%	-4.3%	—	$4.59
MXCTMaxCyte, Inc. Common Stock	C	D	B	—	-21.0%	4.8%	—	$1.30
IBACIB Acquisition Corp. Common Stock	—	D	C	15.9x	-3.7%	—	—	$10.86
ONMDOneMedNet Corp Class A Common Stock	D	A	D	—	-6.8%	—	—	$4.51
BIAFbioAffinity Technologies, Inc. Common Stock	A	C	F	—	-257.3%	—	—	$3.73
ISPCiSpecimen Inc. Common Stock	—	F	F	—	-524.4%	-25.1%	—	$0.92
BIAFWbioAffinity Technologies, Inc. Warrant	—	—	C	—	—	—	—	$0.32
IBACRIB Acquisition Corp. Right	—	D	C	15.9x	-3.7%	—	—	$0.11
NOTVInotiv, Inc. Common Stock	B	B	F	—	-74.7%	53.4%	—	$0.00
OABIWOmniAb, Inc. Warrant	—	—	B	—	—	—	—	$0.24
ONMDWOneMedNet Corp Warrant	—	—	C	—	—	—	—	$0.03

About NRC Health Common Stock

National Research Corp provides analytics and insights that help healthcare providers, payers, and other healthcare organizations measure and improve patient and employee experiences while increasing engagement and loyalty. The company operates primarily in the United States and Canada, with the majority of its revenue derived from the U.S. market.